| The Current Landscape of Machine Perfusion & Preservation | | | | | |
| The Science of Perfusion & Preservation | | | | | |
| National Data on Organ Utilization | | | | | |
| Overview of Technologies Used in Machine Perfusion & Preservation | | | | | |
| Ethical Issues Surrounding Machine Perfusion & Preservation | | | | | |
| Breakout 1: Liver Focus | | | | | |
| Breakout 2: Heart Focus | | | | | |
| Breakout 3: Lung Focus | | | | | |
| Breakout 4: Kidney Focus | | | | | |
| Patient Outcomes & Survival Data | | | | | |
| The Role of Regulation: FDA Processes, Credentialing, and Implications for Patient Safety | | | | | |
| Different Models of Starting a Perfusion & Preservation Program | | | | | |
| Breakout 1: OPO Models | | | | | |
| Breakout 2: Transplant Center Models Cardiothoracic Focus | | | | | |
| Breakout 3: Transplant Center Models Abdominal Focus | | | | | |
| Breakout 4: 3rd Party Models | | | | | |
| Breakout 5: Hybrid Models | | | | | |
| Cost Considerations & Financial Models | | | | | |
| The Future of Perfusion & Preservation and Global Reach | | | | | |